CORT
Corcept Therapeutics Inc
$22.48
Earnings Summary
Revenue | $135.41Mn |
Net Profits | $31.36Mn |
Net Profit Margins | 23.16% |
Highlights
Corcept Therapeutics Inc’s revenue jumped 31.39% since last year same period to $135.41Mn in the Q4 2023. On a quarterly growth basis, Corcept Therapeutics Inc has generated 9.55% jump in its revenue since last 3-months.
Corcept Therapeutics Inc’s net profit jumped 88.87% since last year same period to $31.36Mn in the Q4 2023. On a quarterly growth basis, Corcept Therapeutics Inc has generated -0.07% fall in its net profits since last 3-months.
Corcept Therapeutics Inc’s net profit margin jumped 43.75% since last year same period to 23.16% in the Q4 2023. On a quarterly growth basis, Corcept Therapeutics Inc has generated -8.78% fall in its net profit margins since last 3-months.
Earnings per share (EPS) Estimates
Earnings per share (EPS) estimates of the Corcept Therapeutics Inc post its latest quarter earnings
EPS Estimate Current Quarter | 0.22 |
EPS Estimate Current Year | 0.22 |
Highlights
Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current quarter stand at 0.22 - a -15.38% fall from last quarter’s estimates.
Corcept Therapeutics Inc’s earning per share (EPS) estimates for the current year stand at 0.22.
Key Ratios
Key ratios of the Corcept Therapeutics Inc post its Q4 2023 earnings
Earning Per Share (EPS) | 0.28 |
Highlights
Corcept Therapeutics Inc’s earning per share (EPS) jumped 100% since last year same period to 0.28 in the Q4 2023. This indicates that the Corcept Therapeutics Inc has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2023-11-01 | 0.22 | 0.28 | 27.27% |
2023-05-03 | 0.19 | 0.14 | -26.32% |
2023-08-02 | 0.15 | 0.25 | 66.67% |
2024-02-15 | 0.26 | 0.28 | 7.69% |
₹0 US Stocks a/c Opening Fee